Home/Filings/3/0001388325-25-000015
3//SEC Filing

Novo Holdings A/S 3

Accession 0001388325-25-000015

CIK 0001770069other

Filed

Oct 26, 8:00 PM ET

Accepted

Oct 27, 5:00 PM ET

Size

6.1 KB

Accession

0001388325-25-000015

Insider Transaction Report

Form 3
Period: 2025-10-25
Novo A/S
10% Owner
Holdings
  • Series C Preferred Stock

    Voting Common Stock (1,558,999 underlying)
  • Series D Preferred Stock

    Voting Common Stock (1,174,682 underlying)
Footnotes (1)
  • [F1]The Series C Preferred Stock and Series D Preferred Stock is convertible on a 1-for-16.8 basis into voting common stock at any time at the holder's election and will convert automatically upon the closing of the Issuer's initial public offering and has no expiration date.

Issuer

MapLight Therapeutics, Inc.

CIK 0001770069

Entity typeother
IncorporatedDenmark

Related Parties

1
  • filerCIK 0001388325

Filing Metadata

Form type
3
Filed
Oct 26, 8:00 PM ET
Accepted
Oct 27, 5:00 PM ET
Size
6.1 KB